Alza Corp. v. ANDRX PHARMACEUTICALS, LLC’s Empirical Analysis
2009
Citation profile
1 federal appellate · 13 district ·
Relationships
Applies 21 U.S.C. § 321 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355C (Federal Food, Drug, and Cosmetic Act) · 35 U.S.C. § 103 · 35 U.S.C. § 112 · 35 U.S.C. § 271
Relies on Graham v. John Deere Company of Kansas City Calmar Inc · MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al. · KSR International Co. v. Teleflex Inc. · Markman v. Westview Instruments, Inc. · Colorado v. New Mexico
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 14 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“Clear and convincing evidence is evidence that places in the fact finder 'an abiding conviction that the truth of [the] factual contentions are highly probable.'”
3 later decisions quote this exact passage · from the majority“a release of methylphenidate from the dosage form wherein the amount released in a periodic interval is increased over the amount released during the immediately preceding periodic, interval starting at t=0 and continuing through at least the mid-point of the T90 and for at least three hours. The release rate is determined by an appropriate in-vitro dissolution test. The ascending release rate does not include release of drug from any immediate-release drug coating that may be applied to the dosage form. 4”
1 later decision quote this exact passage · from the majority“There are many approaches to achieving sustained release of drugs from oral dosage forms known in the art. These different approaches include, for example, diffusion systems such as reservoir devices and matrix devices, dissolution systems (including, for example, “tiny time pills”) and matrix dissolution systems, combination diffusion/dissolution systems, osmotic systems and ion-exchange resin systems as described in Remington’s Pharmaceutical Sciences, 1990 ed., pp. 1682-1685.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.